EyePoint Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing innovative ophthalmic products for patients with serious eye disorders. Their proprietary Durasert® technology enables sustained intraocular drug delivery, aiming to reduce the frequency of treatments and improve patient outcomes.